DCM
INSM icon

Dupont Capital Management’s Insmed INSM Stock Holding History

Dupont Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,442
Closed -$206K – 1617
2022
Q2 		$206K Hold
10,442
– – 0.01% 970
2022
Q1 		$245K Sell
10,442
-924
-8% -$21.5K 0.01% 999
2021
Q4 		$310K Buy
11,366
+1,947
+21% +$55.7K 0.01% 961
2021
Q3 		$259K Sell
9,419
-1,332
-12% -$34.9K 0.01% 1122
2021
Q2 		$306K Hold
10,751
– – 0.01% 1193
2021
Q1 		$366K Buy
10,751
+2,120
+25% +$81K 0.01% 1074
2020
Q4 		$287K Sell
8,631
-645
-7% -$23.6K 0.01% 1046
2020
Q3 		$298K Sell
9,276
-622
-6% -$17.9K 0.01% 974
2020
Q2 		$273K Buy
+9,898
New +$235K 0.01% 1005

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dupont Capital Management's INSM Position: Q3 2022 in Review

Dupont Capital Management sold out of Insmed (INSM) in Q3 2022, closing a stake of 10,442 shares — an estimated $206K sold.

Dupont Capital Management first reported a position in INSM in Q2 2020 and held it in 9 quarters. The position peaked at $366K in Q1 2021. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

  • Dupont Capital Management reported no remaining Insmed position as of Q3 2022 after selling out during the quarter.
  • Dupont Capital Management sold 10,442 Insmed shares in Q3 2022, an estimated $206K.
  • Dupont Capital Management first reported a position in Insmed in Q2 2020 and held it in 9 quarters.
  • Dupont Capital Management's Insmed position peaked at $366K in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.